Robert L. Ohsfeldt, PhD

Regents Professor PhD Program Co-Chair Health Policy & Management | School of Public Health
Contact
  • 979.436.9430
  • 212 Adriance Lab Rd., 1266 TAMU
    College Station, TX 77843-1266
Groups and Affiliations Curriculum Vitae

Education

  • PhD, Economics University of Houston, 1983
  • Robert Wood Johnson Foundation Fellow in Healthcare Finance Johns Hopkins University and the Texas Medical Center, 1987-1988

Research Interests

  • Comparative treatment effectiveness using real-world evidence
  • Cost impact and cost-effectiveness analysis
  • Economics of health sector regulation

Teaching Interests

  • Introduction to Health Economics
  • Health Delivery Systems Financing
  • Directed Study

Publications

2020 Predictors of Multiple Emergency Department Utilization among Frequent Emergency Department Users in Three States
Giannouchos, T., Washburn, D., Kum, H., Sage, W., and Ohsfeldt, R., “Predictors of Multiple Emergency Department Utilization among Frequent Emergency Department Users in Three States,” Medical Care 58 [February 2020]: 137-145.
2020 Self-reported Health, Quality and Cost-Related Outcomes of Care Coordination among Patients with Complex Health Needs
Wells, R., Breckenridge, E., Sianez, M., Tamayo, L., Kum, H., and Ohsfeldt, R., “Self-reported Health, Quality and Cost-Related Outcomes of Care Coordination among Patients with Complex Health Needs.” Population Health Management 23 [February 2020]: 59-67.
2019 Hepatocellular Carcinoma Screening is Associated with Improved Survival in Patients with Cirrhosis
Choi, D., Kum, H., Park, S., Ohsfeldt, R., Shen, Y., Parikh, N. and Singal, A., “Hepatocellular Carcinoma Screening is Associated with Improved Survival in Patients with Cirrhosis,” Clinical Gastroenterology and Hepatology 17 [April 2019]: 976-987.
2019 Organ Damage in Patients Treated with Belimumab versus Standard of Care: A Propensity Score Matched Comparative Analysis
Urowitz, M., Ohsfeldt, R., Wielage, R., Kelton, K., Asukai, Y., and Ramachandran, S., “Organ Damage in Patients Treated with Belimumab versus Standard of Care: A Propensity Score Matched Comparative Analysis,” Annals of the Rheumatic Diseases 78 [March 2019]: 372-379.
2018 State Entry Regulation and Home Health Agency Quality
Ohsfeldt, R., and Li, P., “State Entry Regulation and Home Health Agency Quality,” Journal of Regulatory Economics 53 [February 2018]: 1-19.

Accreditations